title: Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: is it true for capecitabine treatment or more?
authors.forename: Cagatay
authors.initials: C
authors.lastname: Arslan
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy*; D004911:Erythrocyte Volume / Q000187:drug effects*; D005260:Female; D006801:Humans; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*
chemical_list: D013940:Thymidylate Synthase